Healthways (HWAY) Target Lowered at Dougherty; Analysts Still 'Cautiously Recommend' Stock
Tweet Send to a Friend
Dougherty & Co maintained a Buy rating on Healthways (NASDAQ: HWAY) and lowered its price target to $17.00 (from $22.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
